SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                 ---------------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                          Date of Report: July 29, 2002
                 Date of earliest event reported: July 28, 2002


                          GENESIS HEALTH VENTURES, INC.
             (Exact name of registrant as specified in its charter)


                                  Pennsylvania
                 (State or other jurisdiction of incorporation)


      00-33217                                            06-1132947
(Commission File No.)                          (IRS Employer Identification No.)

                              101 East State Street
                       Kennett Square, Pennsylvania 19348


          (Address of principal executive offices, including ZIP code)



                                 (610) 444-6350
              (Registrant's telephone number, including area code)

                                 Not Applicable
          (Former name or former address, if changed since last report)







ITEM 5.  OTHER EVENTS.

                  On July 28, 2002, Genesis Health Ventures, Inc. ("Genesis"),
Geneva Sub, Inc., a wholly owned subsidiary of Genesis ("Sub"), and NCS
HealthCare, Inc. ("NCS") entered into a definitive Agreement and Plan of Merger
(the "Merger Agreement"), pursuant to which Sub will merge with and into NCS
(the "Merger"), with NCS surviving as a wholly owned subsidiary of Genesis. If
the Merger is completed, each outstanding share of common stock of NCS, par
value $0.01 per share ("NCS Common Stock"), other than the NCS Common Stock held
by NCS and other than dissenting shares, will be converted into the right to
receive 0.1 of a share of common stock of Genesis, par value $0.02 per share.
The completion of the Merger is subject to regulatory approvals and other
customary conditions, including the approval of the holders of a majority of the
outstanding voting power of NCS Common Stock.

                  At the closing of the Merger, Genesis will repay in full the
outstanding debt of NCS, which includes $206 million of senior debt, and will
redeem $102 million of 5.75% convertible subordinated debentures, including any
accrued and unpaid interest.

                  In connection with the Merger Agreement, on July 28, 2002,
Genesis entered into agreements (the "Voting Agreements") with certain
stockholders of NCS beneficially owning in the aggregate a majority of the
outstanding voting power of NCS Common Stock. In the Voting Agreements, such
stockholders agreed (1) to vote their shares of NCS Common Stock in favor of
adoption and approval of the Merger Agreement and against proposals for certain
other transactions and (2) not to transfer their shares of NCS Common Stock
prior to the consummation of the Merger. The foregoing descriptions of the
Merger, the Merger Agreement and the Voting Agreements are qualified in their
entirety by reference to the text of the Merger Agreement and the Voting
Agreements, which are attached hereto as Exhibits 2.1, 10.1 and 10.2,
respectively, and are incorporated herein by reference.

                  On July 29, 2002, Genesis issued a press release announcing
the Merger Agreement and the related transactions. The press release is attached
hereto as Exhibit 99.1 and is incorporated herein by reference.

ITEM 7.    FINANCIAL STATEMENTS, PRO FORMA FINANCIAL STATEMENTS, AND EXHIBITS

         (c)      Exhibits.

2.1      Agreement and Plan of Merger, dated as of July 28, 2002, by and among
         Genesis Health Ventures, Inc., Geneva Sub, Inc. and NCS HealthCare,
         Inc.

10.1     Voting Agreement, dated as of July 28, 2002, by and among Jon H.
         Outcalt, NCS HealthCare, Inc. and Genesis Health Ventures, Inc.

10.2     Voting Agreement, dated as of July 28, 2002, by and among Kevin B.
         Shaw, NCS HealthCare, Inc. and Genesis Health Ventures, Inc.

99.1     Press Release dated July 29, 2002.






                                    SIGNATURE

                  Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.


Dated:  July 29, 2002

                                          GENESIS HEALTH VENTURES, INC.



                                          By:  /s/ George V. Hager, Jr.
                                             -----------------------------------
                                          Name:  George V. Hager, Jr.
                                          Title: Executive Vice President and
                                                 Chief Financial Officer





                                  EXHIBIT LIST


     Exhibit                                           Description
       No.                                             -----------
       ---
       2.1          Agreement and Plan of Merger, dated as of July 28, 2002, by
                    and among Genesis Health Ventures, Inc., Geneva Sub, Inc.
                    and NCS HealthCare, Inc.

      10.1          Voting Agreement, dated as of July 28, 2002, by and among
                    Jon H. Outcalt, NCS HealthCare, Inc. and Genesis Health
                    Ventures, Inc.

      10.2          Voting Agreement, dated as of July 28, 2002, by and among
                    Kevin B. Shaw, NCS HealthCare, Inc. and Genesis Health
                    Ventures, Inc.

      99.1          Press Release dated July 29, 2002.